{"gao_id": "GAO-20-341", "published": "2020-03-30T12:00:00Z", "released": "2020-04-29T08:00:00Z", "summary": "Antibiotic-resistant infections can be difficult or impossible to treat. We examined federal challenges to addressing antibiotic resistance: Surveillance \u2014Tracking resistant infections is tough because of reliance on sampling and voluntary reporting Diagnostics \u2014Lack of data on clinical outcomes impedes the development and use of antibiotic-resistance tests New treatments \u2014The pipeline of new antibiotics is inadequate and federal efforts haven\u2019t fully incentivized development Antibiotic use \u2014Federal...", "title": "Antibiotic Resistance: Additional Federal Actions Needed to Better Determine Magnitude and Reduce Impact", "topics": ["Bacteria", "Patient care", "Clinical trials", "Antibiotics", "Infectious diseases", "Bacterial infections", "Antimicrobial resistance", "Health care facilities", "Disease control", "Health Care", "Research and development", "Antibiotic-resistance", "Drugs", "Hospitals"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-20-341", "versions": [{"title": "Highlights Page (2 pages)", "url": "https://www.gao.gov/assets/gao-20-341-highlights.pdf"}, {"title": "Full Report (135 pages)", "url": "https://www.gao.gov/assets/gao-20-341.pdf"}, {"title": "Accessible PDF (156 pages)", "url": "https://www.gao.gov/assets/710/707324.pdf"}]}